Grants and Contributions:

Back to search

Title:

Development of a THCA Extraction Process

Agreement Number:

1032755

Agreement Value:

$90,646.00

Agreement Date:

Jun 15, 2025 - Mar 15, 2026

Description:

There is large market demand for THCA, a component of the cannabis plant and a well-known precursor of THC. Its popularity is due to the ease of calculating dosage amounts, its powder format and its availability to provide a round about way of producing high potency THC (>98%). The current method of THCA preparation, requires a C1D1 (Class 1 Division 1 safety requirements) extraction environment and is therefore capital-intensive, high risk and difficult when trying to achieve scale-up. The objective of this project is to develop a new procedure to extract THCA (Phase I) and to scale to commercial production (Phase II). Key activities for phase I of the project, will include process development, optimization, refinement and testing.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Leduc, Alberta, CA T9E 0Z4

Reference Number:

172-2025-2026-Q2-1032755

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

720710318

Recipient Type:

For-profit organization

Recipient's Operating Name:

PBG

Recipient's Legal Name:

PBG BioPharma Inc.

Federal Riding Name:

Edmonton--Wetaskiwin

Federal Riding Number:

48021

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

325410